Holen Sie sich die Stockscreener-App
121.41
1.82%
2.17
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$119.24
Offen:
$121.5
24-Stunden-Volumen:
10.10M
Relative Volume:
0.70
Marktkapitalisierung:
$301.34B
Einnahmen:
$65.00B
Nettoeinkommen (Verlust:
$18.26B
KGV:
16.69
EPS:
7.2751
Netto-Cashflow:
$13.05B
1W Leistung:
-0.43%
1M Leistung:
+12.15%
6M Leistung:
+46.79%
1J Leistung:
+43.82%
1-Tages-Spanne:
$121.03
$123.33
1-Wochen-Bereich:
$116.10
$123.33
52-Wochen-Spanne:
$73.31
$123.33
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN, NVS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
121.41 | 295.96B | 65.00B | 18.26B | 13.05B | 7.2751 |
|
LLY
Lilly Eli Co
|
1,040.00 | 929.27B | 65.18B | 20.64B | 6.44B | 22.96 |
|
JNJ
Johnson Johnson
|
243.45 | 589.19B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
231.50 | 402.08B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
AZN
Astrazeneca Plc
|
205.55 | 317.06B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
163.10 | 307.56B | 54.72B | 14.02B | 15.32B | 7.1855 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co., Inc. (NYSE:MRK) Hits New 1-Year High Following Analyst Upgrade - MarketBeat
Merck & Co. (MRK) Announces FDA Approval of KEYTRUDA and KEYTRUDA QLEX Plus Paclitaxel, With or Without Bevacizumab, to Treat Adults With PD-L1+ - Finviz
Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug? - The Motley Fool
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Upgraded to Buy at Deutsche Bank Aktiengesellschaft - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Metis Global Partners LLC - MarketBeat
Mraz Amerine & Associates Inc. Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Savvy Advisors Inc. - MarketBeat
Insider Sell Alert: Chirfi Guindo Sells 10,000 Shares of Merck & Co Inc (MRK) - GuruFocus
Merck & Co., Inc. $MRK Shares Acquired by Varma Mutual Pension Insurance Co - MarketBeat
Krilogy Financial LLC Buys 21,122 Shares of Merck & Co., Inc. $MRK - MarketBeat
Caprock Group LLC Invests $5.33 Million in Merck & Co., Inc. $MRK - MarketBeat
Atria Investments Inc Has $15.08 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
ABC Arbitrage SA Buys Shares of 11,779 Merck & Co., Inc. $MRK - MarketBeat
Merck's Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer Patients - Benzinga
Rhumbline Advisers Sells 8,850 Shares of Merck & Co., Inc. $MRK - MarketBeat
Stratos Wealth Partners LTD. Acquires 26,639 Shares of Merck & Co., Inc. $MRK - MarketBeat
Wealthfront Advisers LLC Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
ING Groep NV Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Edgemoor Investment Advisors Inc. Cuts Stake in Merck & Co., Inc. $MRK - MarketBeat
Advisors Asset Management Inc. Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Insider Sell Alert: Dean Li Sells Shares of Merck & Co Inc (MRK) - GuruFocus
Merck & Co., Inc. $MRK Shares Sold by Wesbanco Bank Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Applied Finance Capital Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ProShare Advisors LLC - MarketBeat
Rockland Trust Co. Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Midwest Trust Co Purchases 24,910 Shares of Merck & Co., Inc. $MRK - MarketBeat
Rothschild & Co Redburn Adjusts Price Target on Merck & Co. to $140 From $135, Maintains Buy Rating - marketscreener.com
Merck & Co., Inc. $MRK Position Increased by Providence Capital Advisors LLC - MarketBeat
Costello Asset Management INC Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Price, Forecast & Analysis | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Insider Sell: Chirfi Guindo Sells 10,000 Shares of Merck & Co In - GuruFocus
Merck & Co., Inc. (NYSE:MRK) EVP Sells $14,485,422.95 in Stock - MarketBeat
Chirfi Guindo Sells 10,000 Shares of Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck: The Spike Doesn't Make It Overvalued (NYSE:MRK) - Seeking Alpha
Merck Stock Surged 40% Last Year. Is it Still a Buy in 2026? - TIKR.com
Merck: A Buy For 2026, But The Clock Is Still Ticking (NYSE:MRK) - Seeking Alpha
OPTIMAS CAPITAL Ltd Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Oppenheimer Asset Management Inc. Has $46.50 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Alps Advisors Inc. Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Reduced by Candriam S.C.A. - MarketBeat
From Bargain To Balancing Act: Merck's Next Test Begins (Rating Downgrade) - Seeking Alpha
Merck: Pipeline Building Despite The Light FY26 Guide, Major Momentum - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Cut to "Buy" at Wall Street Zen - MarketBeat
Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface - TechStock²
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
Merck & Co., Inc. $MRK Shares Bought by Canada Post Corp Registered Pension Plan - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Garland Capital Management Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Prime Capital Investment Advisors LLC - MarketBeat
Insider Sell Alert: Johannes Oosthuizen Sells 15,000 Shares of M - GuruFocus
Merck & Co., Inc. (NYSE:MRK) EVP David Michael Williams Sells 5,000 Shares - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):